Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 S... von Peters, S., Dafni, U., Dómine, M., Popat, S., Andrade, J., Becker, A., Moro-Sibilot, D., Curioni-Fontecedro, A., Molinier, O., Nackaerts, K., Insa Mollá, A., López Vivanco, G., Madelaine, J., Faehling, M., Griesinger, F., González Larriba, J.L., Provencio Pulla, M., Vervita, K., Roschitzki-Voser, H., Ruepp, B., Mitchell, P., Le Pechoux, C., De Ruysscher, D., Stahel, R., Hiltbrunner, A., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Pfister, R., Piguet, A.C., Roux, S., Troesch, S., Schweri, R., Zigomo, I., Tsourti, Z., Tsouprou, S., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Morin, F., Amour, E., Mariaule, G., Archirel, N., Fernandez, M., Pereira, E., Benito, L., Lopez, K., Hernández, A., Chinchen, S., Jurkovic, H., Livingstone, A., Walker, M., Mitchell, P., Ng, S., Steer, C., Briscoe, K., Saqib, A., O’Byrne, K., Chittajallu, B.R., Hughes, B.G., Black, A., Nackaerts, K., Werner, H., Gervais, R., Zalcman, G., Monnet, I., Moro-Sibilot, D., Molinier, O., Girard, N., Souquet, P.-J., Barlesi, F., Debieuvre, D., Senellart, H., Poudenx, M., Dixmier, A., Pouessel, D., Cadranel, J., Lena, H., Quoix, E., Friard, S., Audigier-Valette, C., Mazieres, J., Pichon, E., Faehling, M., Kokowski, K., Griesinger, F., Tufman, A., de Langen, J., González Larriba, J.L., Insa, A., Massutí, B., Pulla, M.P., Aix, S.P., Villanueva, N., Andrade, J., Curioni-Fontecedro, A., Franks, K., Califano, R.

Volltext

Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study von Lecumberri, R, López Vivanco, G, Font, A, González Billalabeitia, E, Gúrpide, A, Gómez Codina, J, Isla, D, Galán, A, Bover, I, Domine, M, Vicente, V, Rosell, R, Rocha, E

Volltext

Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Ran... von ALBEROLA, V, CAMPS, C, GONZALEZ-LARRIBA, J. L, DIZ, P, CARDENAL, F, ARTAL, A, CARRATO, A, MORALES, S, SANCHEZ, J. J, DE LAS PENAS, R, FELIP, E, LOPEZ-VIVANCO, G, PROVENCIO, M, ISLA, D, ROSELL, R, VADELL, C, BOVER, I, RUIZ-CASADO, A, AZAGRA, P, JIMENEZ, U

Volltext

Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer von Muñoz, A., Carrera, S., Ferreiro, J., Ruiz de Lobera, A., Mañé, J.M., López-Vivanco, G.

Volltext

Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer von Isla, D., Sarries, C., Rosell, R., Alonso, G., Domine, M., Taron, M., Lopez-Vivanco, G., Camps, C., Botia, M., Nuñez, L., Sanchez-Ronco, M., Sanchez, J. J., Lopez-Brea, M., Barneto, I., Paredes, A., Medina, B., Artal, A., Lianes, P.

Volltext

Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study von Cardenal, F, Domine, M, Massutı́, B, Carrato, A, Felip, E, Garrido, P, Juan, O, Artal, A, Barneto, I, López-Vivanco, G, Balcells, M, Rosell, R

Volltext

Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain von Lopez-Vivanco, G., Salvador, J., Diez, R., López, D., De Salas-Cansado, M., Navarro, B., De la Haba-Rodríguez, J.

Volltext

P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer Patients Who Benefit from Neoadjuvant Chemo-Immunotherapy von Robado de Lope, L., Nadal, E., Calvo, V., González-Larriba, J.L., Insa, A., Martinez-Marti, A., Massutí, B., González, C., Serna Blasco, R., Bosch-Barrera, J., Garcia-Campelo, M.R., Ponce, S., Reguart, N., Bernabé, R., Cobo, M., De Castro, J., Dómine, M., Camps, C., Barneto, I., López-Vivanco, G., Majem, M., Rodríguez-Abreu, D., Palmero, R., Cruz-Bermudez, A., Romero, A., Provencio, M.

Volltext

EP1.04-07 Influence of Radiotherapy in Second-Line Treatment with Immunotherapy in Patients with Non-Small Cell Lung Cancer von Azkona, E., Carrera, S., Rubio, I., Mañe, J.M., Lacambra, I., Sancho, A., Novo, E., López-Vivanco, G.

Volltext

PL03.12 Progression Free Survival and Overall Survival in NADIM II Study von Provencio, M., Serna, R., Nadal, E., Glez Larriba, J.L., Martínez-Martí, A., Bernabé, R., Bosch-Barrera, J., Garcia Benito, C., Calvo, V., Insa, A., Ponce, S., Reguart, N., De Castro, J., Massutí, B., Palmero, R., Aguado de la Rosa, C., Mosquera, J., Cobo, M., Aguilar, A., López Vivanco, G., Camps, C., Hernando Trancho, F., López Castro, R., Moran, T., Barneto, I., Rodríguez-Abreu, D., Romero, A.

Volltext

MA16.04 Circulating Tumor DNA Quantification by NGS Should Be Adapted to the Methodology Used von Serna Blasco, R., Nadal, E., Calvo, V., Gonzalez-Larriba, J.L., Insa, A., Massutí, B., Garcia-Campelo, M.R., Martinez-Marti, A., Casal, J., Garrido Fernandez, A., Bosch-Barrera, J., Dómine, M., De Castro, J., Ponce, S., Majem, M., Rodriguez-Abreu, D., Reguart, N., Bernabé, R., Barneto, I., Cobo, M., Camps, C., López Vivanco, G., Del Barco, E., Aguilar, A., Moran, T., Lopez-Castro, R., Cruz-Bermúdez, A., Romero, A., Provencio, M.

Volltext

OA02.03 Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial von Casarrubios, M., Cruz-Bermúdez, A., Sierra-Rodero, B., Martinez, C., Nadal, E., Calvo, V., Insa, A., García- Campelo, M.d.R., Gonzalez Ojea, C., Dómine, M., Majem, M., Rodríguez-Abreu, D., Martínez-Martí, A., De Castro Carpeño, J., Cobo, M., López-Vivanco, G., Del Barco, E., Bernabé, R., Massutí, B., Provencio, M.

Volltext

OA20.01 Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study von Provencio, M., Nadal, E., Insa, A., Campelo, M.R. García, Pereiro, D., Domine, M., Majem, M., Abreu, D. Rodriguez, Martinez-Marti, A., De Castro, J., Cobo, M., Vivanco, G. López, Del Barco, E., Bernabé, R., Viñolas, N., Barneto, I., Viteri, S., Pereira, E., Royuela, A., Casarrubios, M., Salas, C., Parra, E.R., Wistuba, I., Calvo, V., Laza - Briviesca, R., Romero, A., Massuti, B., Cruz, A.

Volltext

BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial von Massuti Sureda, B., Sanchez Torres, J.M., Cobo Dols, M., Moran Bueno, M.T., Gonzalez-Larriba, J.L., Barneto Aranda, I.C., De Castro Carpeno, J., Iglesias, L., Muñoz, M.A., López Vivanco, G., Isla Casado, M.D., López, R., de las Penas Bataller, R., Rodriguez Abreu, D., Artal-Cortes, A., Esteban, E., Provencio, M., Pereira, E., Sanchez-Paya, J., Rosell, R.

Volltext

1439PDBRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial von Massuti Sureda, B, Sanchez Torres, J M, Cobo Dols, M, Moran Bueno, M T, Gonzalez-Larriba, J L, Barneto Aranda, I C, De Castro Carpeno, J, Iglesias, L, Muñoz, M A, López Vivanco, G, Isla Casado, M D, López, R, de las Penas Bataller, R, Rodriguez Abreu, D, Artal-Cortes, A, Esteban, E, Provencio, M, Pereira, E, Sanchez-Paya, J, Rosell, R

Volltext

P60.07 TMB and Selected Mutations in Resectable Stage IIIA NSCLC Patients Receiving Neo-Adjuvant Chemo-Immunotherapy from NADIM Trial von Cruz-Bermudez, A., Casarrubios, M., Briviesca, R. Laza, Nadal, E., Insa, A., Mosquera, J., Huidobro, G., Gómez, M. Dómine, Massuti, B., Tarruella, M. Majem, Rodríguez-Abreu, D., Martinez-Marti, A., De Castro Campeño, J., Dols, M. Cobo, Vivanco, G. López, Del Barco, E., Caro, R. Bernabé, Viñolas, N., Barneto, I., Viteri, S., Jove, M., Romero, A., Franco, F., Provencio, M.

Volltext

P60.11 TCR Repertoire Predicts Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy from NADIM Trial von Casarrubios, M., Nadal, E., Cruz-Bermudez, A., Insa, A., Briviesca, R. Laza, Campelo, M.R. Garcia, Sierra-Rodero, B., Casal, J., Dómine, M., Massuti, B., Tarruella, M. Majem, Rodríguez-Abreu, D., Martinez-Marti, A., De Castro Campeño, J., Dols, M. Cobo, Vivanco, G. López, Del Barco, E., Caro, R. Bernabé, Viñolas, N., Barneto, I., Viteri, S., Jove, M., Franco, F., Provencio, M.

Volltext

1241P - Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients von Laza-Briviesca, R., Cruz-Bermudez, A., Casarrubios, M., Nadal, E., Molla, M A Insa, García-Campelo, M.-R., Huidobro, G., Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A., De Carpeno, JCastro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E., Bernabé, R., Viñolas, N., Aranda, I C Barneto, Sureda, B Massuti, Provencio, M.

Volltext

1241PImmune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients von Laza-Briviesca, R, Cruz-Bermudez, A, Casarrubios, M, Nadal, E, Molla, M A Insa, García-Campelo, M-R, Huidobro, G, Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A, Carpeno, J De Castro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E, Bernabé, R, Viñolas, N, Aranda, I C Barneto, Sureda, B Massuti, Provencio, M

Volltext

Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients von Laza-Briviesca, R., Cruz-Bermudez, A., Casarrubios, M., Nadal, E., Molla, M A Insa, García-Campelo, M.-R., Huidobro, G., Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A., De Carpeno, JCastro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E., Bernabé, R., Viñolas, N., Aranda, I C Barneto, Sureda, B Massuti, Provencio, M.

Volltext